EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy

Gül Kilinç iD, Ralf Boland iD, Matthias T Heemskerk iD, Herman P Spaink iD, Mariëlle C Haks iD, Michiel van der Vaart iD, Tom H M Ottenhoff iD, Annemarie H Meijer iD, Anno Saris iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00167-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Gül Kilinç und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Amiodarone, Autophagy, Zebrafish, Macrophages. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking - RespiriNTM, Innovative Medicines Initiative 2 Joint Undertaking - RespiriTB, NWO Domain Applied and Engineering Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis ( Mtb ) as well as nontuberculous mycobacteria are intracellular pathogens whose treatment is extensive and increasingly impaired due to the rise of mycobacterial drug resistance. The loss of antibiotic efficacy has raised interest in the identification of host-directed therapeutics (HDT) to develop novel treatment strategies for mycobacterial infections. In this study, we identified amiodarone as a potential HDT candidate that inhibited both intracellular Mtb and Mycobacterium avium in primary human macrophages without directly impairing bacterial growth, thereby confirming that amiodarone acts in a host-mediated manner. Moreover, amiodarone induced the formation of (auto)phagosomes and enhanced autophagic targeting of mycobacteria in macrophages. The induction of autophagy by amiodarone is likely due to enhanced transcriptional regulation, as the nuclear intensity of the transcription factor EB, the master regulator of autophagy and lysosomal biogenesis, was strongly increased. Furthermore, blocking lysosomal degradation with bafilomycin impaired the host-beneficial effect of amiodarone. Finally, amiodarone induced autophagy and reduced bacterial burden in a zebrafish embryo model of tuberculosis, thereby confirming the HDT activity of amiodarone in vivo . In conclusion, we have identified amiodarone as an autophagy-inducing antimycobacterial HDT that improves host control of mycobacterial infections. IMPORTANCE Due to the global rise in antibiotic resistance, there is a strong need for alternative treatment strategies against intracellular bacterial infections, including Mycobacterium tuberculosis ( Mtb ) and non-tuberculous mycobacteria. Stimulating host defense mechanisms by host‐directed therapy (HDT) is a promising approach for treating mycobacterial infections. This study identified amiodarone, an antiarrhythmic agent, as a potential HDT candidate that inhibits the survival of Mtb and Mycobacterium avium in primary human macrophages. The antimycobacterial effect of amiodarone was confirmed in an in vivo tuberculosis model based on Mycobacterium marinum infection of zebrafish embryos. Furthermore, amiodarone induced autophagy and inhibition of the autophagic flux effectively impaired the host-protective effect of amiodarone, supporting that activation of the host (auto)phagolysosomal pathway is essential for the mechanism of action of amiodarone. In conclusion, we have identified amiodarone as an autophagy-inducing HDT that improves host control of a wide range of mycobacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmiodaroneAutophagyZebrafishMacrophagesMycobacterium tuberculosisTuberculosisAnimalsHumansDisease Models, AnimalMycobacterium aviumLysosomes

Stichwörter der Autor:innen

Mycobacterium aviumMycobacterium marinumMycobacterium tuberculosisamiodaronehost-directed therapyhuman macrophageszebrafish

Substanzen

Amiodarone

Autor:innen und Institutionen

  • Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Institute of Biology Leiden, Leiden University, Leiden, the Netherlands.

ORCID-Profile: Gül Kilinç, Ralf Boland, Matthias T Heemskerk, Herman P Spaink, Mariëlle C Haks, Michiel van der Vaart, Tom H M Ottenhoff, Annemarie H Meijer, Anno Saris

Förderung

  • Innovative Medicines Initiative 2 Joint Undertaking - RespiriNTM
  • Innovative Medicines Initiative 2 Joint Undertaking - RespiriTB
  • NWO Domain Applied and Engineering Sciences

Zitieren

APA

Kilinç, G., Boland, R., Heemskerk, M. T., Spaink, H. P., Haks, M. C., van der Vaart, M., Ottenhoff, T. H. M., Meijer, A. H., & Saris, A. (2024). Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00167-24

Vancouver

Kilinç G, Boland R, Heemskerk MT, Spaink HP, Haks MC, van der Vaart M, et al. Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00167-24

BibTeX
@article{Kilin2024,
  author = {Kilinç, Gül and Boland, Ralf and Heemskerk, Matthias T and Spaink, Herman P and Haks, Mariëlle C and van der Vaart, Michiel and Ottenhoff, Tom H M and Meijer, Annemarie H and Saris, Anno},
  title = {Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00167-24}
}
Kostenlos starten →